ABCDE
1Main
2Brand NameSeroquel, XR
3Indicationschizophrenia, bipolar disorder
4Mechanismatypical antipsychotic
5SafetyLess EPS side effects relative to class, more favorable weight gain vs Zyprexa but equal to Risperdal.
6Price7% increase 1/2006
7CompetitionZyprexa, Abilify, Risperidone/Invega
8Follow-onSeroquel SR will be qd dosing, effect as early as Day 2 and with faster titration.
9IPSeptember 2011 expiry. Pediatric extension applicable.
10June 4 2008 summary judgment hearing with Teva? August 20 2008 30-month stay expiry. Summary judgment granted and no inequitable conduct found.
11Anchen filed P4 in March 2010.
12Sues Osmotica and Torrent 8/2010.
13Clinical StudiesBOLDER I and BOLDER II bipolar studies (n=1045). PDUFA 10/30.
14MDD, GAD
15
16Seroquel SR data at ECP.
17
18
19RxTRxNRx
206/1/2007287913141565
215/25/2007297841152431
226/1/2006264850130220